修正:GTVnxと組み合わせた単細胞数は,放射線治療を受けた非転移性鼻がんにおける独立した予後因子である

Li-Na Yang1, Yun-Rui Song1, Huan Zhang1

  • 1Radiation Oncology Center, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, China.

Frontiers in oncology
|September 5, 2025
PubMed
まとめ

この研究は,以前に発表された論文 DOI を訂正しています. 正確な引用と内容については,更新された情報を参照してください.

関連する概念動画

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K